Retatrutide, a new injectable drug candidate from Eli Lilly, is delivering stunning weight loss in clinical trials. Doctors are comparing the results so far to bariatric surgery, calling it the ...

It's being described as the best weight-loss jab yet –with results that outstrip Wegovy or Mounjaro. But anyone hoping to try retatrutide (also known as Triple G) should beware. For while the drug has ...

June 26 (Reuters) - Eli Lilly LLY.N on Monday said a mid-stage trial of its next-generation obesity drug candidate "triple G" showed that it led to weight loss of up to 24.2% after 48 weeks, ...

Weight-loss drugs like semaglutide, tirzepatide, and liraglutide help regulate appetite and digestion. They work by acting on a hormone called GLP-1, but some may be more effective than others. Newer ...

Novo Nordisk has acquired the global rights to China-based United Laboratories’ triple-agonist weight-loss and diabetes drug in a deal worth up to $2bn as the Wegovy (semalgutide) developer seeks a ...

A 19-year-old woman’s breasts stunningly grew from a B cup to a triple G in the six months following her Pfizer COVID-19 vaccination in what researchers are calling a first-of-its-kind case. The ...